Published in Nat Immunol on February 01, 2008
Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med (2010) 2.17
Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur J Immunol (2010) 1.13
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells. J Leukoc Biol (2012) 1.00
Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression. J Immunol (2009) 0.94
Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. Int J Clin Exp Med (2014) 0.90
LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn's disease. J Biomed Sci (2013) 0.79
TLR5 signaling enhances the proliferation of human allogeneic CD40-activated B cell induced CD4hiCD25+ regulatory T cells. PLoS One (2013) 0.78
Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate. J Autoimmun (2011) 0.75
Diverse continuum of CD4(+) T-cell states is determined by hierarchical additive integration of cytokine signals. Proc Natl Acad Sci U S A (2017) 0.75
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol (2007) 6.22
Projection of an immunological self shadow within the thymus by the aire protein. Science (2002) 12.15
Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol (2005) 9.91
Origin of regulatory T cells with known specificity for antigen. Nat Immunol (2002) 7.49
Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature (2007) 5.81
In vivo instruction of suppressor commitment in naive T cells. J Exp Med (2004) 5.47
DNA methylation controls Foxp3 gene expression. Eur J Immunol (2008) 4.19
In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A (2003) 4.18
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12
Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity (2006) 3.92
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer (2006) 3.89
Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell (2003) 3.86
Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol (2004) 2.82
Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity (2007) 2.51
The requirement for cyclin D function in tumor maintenance. Cancer Cell (2012) 2.49
Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci U S A (2010) 2.30
TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A (2009) 2.13
Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology (2008) 2.00
Identification of a T lineage-committed progenitor in adult blood. Immunity (2007) 2.00
Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol (2003) 1.97
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J Exp Med (2011) 1.94
A critical role for the cytoplasmic tail of pTalpha in T lymphocyte development. Nat Immunol (2002) 1.88
Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol (2002) 1.81
Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes (2004) 1.73
Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol (2004) 1.72
Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity (2006) 1.70
Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J Exp Med (2009) 1.69
The transcriptional landscape of αβ T cell differentiation. Nat Immunol (2013) 1.61
A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus. Proc Natl Acad Sci U S A (2006) 1.59
Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci U S A (2002) 1.54
Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer. Immunol Rev (2006) 1.50
Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med (2008) 1.49
Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood (2007) 1.48
PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J Exp Med (2010) 1.47
The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med (2005) 1.46
Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A (2002) 1.44
c-Myc mediates pre-TCR-induced proliferation but not developmental progression. Blood (2006) 1.39
Analysis and expression of a cloned pre-T cell receptor gene. Science. 1994. 266: 1208-1212. J Immunol (2009) 1.39
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J Exp Med (2003) 1.39
Tracing lymphopoiesis with the aid of a pTalpha-controlled reporter gene. Nat Immunol (2002) 1.30
T cell receptor-instructed alphabeta versus gammadelta lineage commitment revealed by single-cell analysis. J Exp Med (2008) 1.30
Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc Natl Acad Sci U S A (2008) 1.30
Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med (2006) 1.29
On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes (2005) 1.29
Pre-TCRalpha and TCRalpha are not interchangeable partners of TCRbeta during T lymphocyte development. J Exp Med (2004) 1.28
The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol (2006) 1.23
Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene (2002) 1.22
Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J Biol Chem (2009) 1.22
Enhancement of antigen-specific Treg vaccination in vivo. Proc Natl Acad Sci U S A (2010) 1.21
On the brink of becoming a T cell. Curr Opin Immunol (2002) 1.21
Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J Exp Med (2011) 1.21
Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep (2003) 1.18
Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling. Blood (2006) 1.15
Peripherally induced Treg: mode, stability, and role in specific tolerance. J Clin Immunol (2008) 1.14
Characterization of T cell differentiation in the murine gut. J Exp Med (2002) 1.14
Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping. PLoS One (2008) 1.14
Visualizing the course of antigen-specific CD8 and CD4 T cell responses to a growing tumor. Eur J Immunol (2003) 1.14
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J Exp Med (2013) 1.14
De novo production of antigen-specific suppressor cells in vivo. Nat Protoc (2006) 1.12
Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med (2012) 1.12
Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood (2009) 1.11
Phenotypic plasticity of T cell progenitors upon exposure to Notch ligands. J Exp Med (2006) 1.07
Constitutive endocytosis and degradation of the pre-T cell receptor. J Exp Med (2002) 1.05
Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc Natl Acad Sci U S A (2010) 1.01
Multiple extrathymic precursors contribute to T-cell development with different kinetics. Blood (2009) 1.00
αβ versus γδ fate choice: counting the T-cell lineages at the branch point. Immunol Rev (2010) 1.00
TCR and Notch synergize in alphabeta versus gammadelta lineage choice. Trends Immunol (2007) 1.00
Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity. Semin Immunol (2006) 0.98
Lymphocyte development: overview. Curr Opin Immunol (2008) 0.97
BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation. J Biol Chem (2003) 0.96
Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes. J Exp Med (2003) 0.94
Alphabeta versus gammadelta lineage choice at the first TCR-controlled checkpoint. Curr Opin Immunol (2010) 0.94
PLZF Controls the Expression of a Limited Number of Genes Essential for NKT Cell Function. Front Immunol (2012) 0.92
β-Selection-induced proliferation is required for αβ T cell differentiation. Immunity (2012) 0.92
The E delta enhancer controls the generation of CD4- CD8- alphabetaTCR-expressing T cells that can give rise to different lineages of alphabeta T cells. J Exp Med (2006) 0.90
gammadeltaTCR ligands and lineage commitment. Semin Immunol (2010) 0.87
Regulatory T cells and antigen-specific tolerance. Chem Immunol Allergy (2008) 0.85
Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease. Adv Immunol (2011) 0.84
Negative selection, not receptor editing, is a physiological response of autoreactive thymocytes. J Exp Med (2013) 0.82
Antigen-specific induction of regulatory T cells in vivo and in vitro. Methods Mol Biol (2011) 0.82
Mechanisms of self-nonself discrimination and possible clinical relevance. Immunotherapy (2009) 0.80
Thymocyte selection: chemokine signaling is not only about the destination. Curr Biol (2010) 0.79
Notch in lymphopoiesis and T cell polarization. Nat Immunol (2005) 0.78
p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis. Blood (2007) 0.77
Notch Signaling in T-Cell Development and T-ALL. ISRN Hematol (2011) 0.76
Extra-thymically induced regulatory T cells: do they have potential in disease prevention? Semin Immunol (2011) 0.76
Positive selection by the pre-TCR yields mature CD8+ T cells. J Immunol (2002) 0.75
Type 1 diabetes: focus on prevention. Nat Med (2004) 0.75
Pulling the trigger on the tumor's bodyguards: what puts Tregs out of action? Immunotherapy (2011) 0.75